Bath & Body Works generated fourth quarter net sales of 2724000000, down slightly from the prior year, while net income declined to 403000000 and operating income decreased to 599000000. Despite the year-over-year decline, the company exceeded its internal guidance and continued executing strategic initiatives focused on brand modernization, innovation, and distribution expansion.

Bath & Body Works saw a modest decline in Q3 revenue and net income, missing expectations amid continued macroeconomic pressures. The company launched a new strategic transformation plan aimed at long-term growth, while also lowering its guidance for Q4 and the full year.

Bath & Body Works delivered Q2 results with revenue reaching $1.549B, up 1.5% year-over-year. While GAAP earnings were lower due to one-time costs, adjusted EPS matched last year's result. The company also raised the low end of its FY25 guidance.

The company delivered strong Q1 results driven by product innovation and efficient supply chain execution, with both revenue and earnings per share exceeding expectations.

Bath & Body Works reported Q4 2024 net sales of $2.788 billion, a 4.3% decline due to an extra week in the prior year. EPS was $2.09, down from $2.55 last year. Operating income fell to $678 million, while net income dropped to $453 million. Despite these declines, results exceeded company guidance.

Bath & Body Works reported strong Q3 2024 results, exceeding net sales and earnings per diluted share guidance. Net sales increased by 3.0% to $1.61 billion, and earnings per diluted share were $0.49. The company is raising its full-year guidance to reflect this outperformance.

Bath & Body Works reported Q2 2024 net sales of $1.526 billion, a 2.1% decrease compared to the previous year. Earnings per diluted share were $0.68, while adjusted earnings per diluted share were $0.37, exceeding guidance. The company has updated its fiscal year 2024 guidance and increased its full-year expected share repurchases to $400 million.

Bath & Body Works reported net sales of $1.384 billion for Q1 2024, a decrease of 0.9% compared to $1.396 billion in Q1 2023. Earnings per diluted share were $0.38, up 9% compared to $0.35 in the same period last year. The company narrowed its full-year guidance range while raising the midpoint for both the top- and bottom-lines.

Bath & Body Works reported a 5% decrease in net sales for the fourth quarter of 2022 compared to the prior year, totaling $2.889 billion. Despite a challenging macroeconomic environment, the company delivered better-than-expected earnings results, with diluted EPS of $1.86.

Bath & Body Works reported Q2 2023 net sales of $1.559 billion, a decrease of 3.6% compared to the previous year. EPS was $0.43, and operating income was $188 million. The company has updated its full-year forecast to reflect better-than-expected bottom line results.